1. Home
  2. PCRX vs TFIN Comparison

PCRX vs TFIN Comparison

Compare PCRX & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

SELL

Current Price

$36.48

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Logo Triumph Financial Inc.

TFIN

Triumph Financial Inc.

SELL

Current Price

$59.52

Market Cap

1.4B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PCRX
TFIN
Founded
2006
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
PCRX
TFIN
Price
$36.48
$59.52
Analyst Decision
Hold
Buy
Analyst Count
9
5
Target Price
$33.57
★ $76.00
AVG Volume (30 Days)
★ 958.5K
214.0K
Earning Date
11-09-2026
10-21-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 107.44
72.22
EPS
0.89
★ 1.19
Revenue
★ $541,533,000.00
N/A
Revenue This Year
$3.84
$9.34
Revenue Next Year
$4.73
$10.35
P/E Ratio
★ $40.96
$50.26
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$49.27
52 Week High
$36.67
$83.52

Technical Indicators

Market Signals
Indicator
PCRX
TFIN
Relative Strength Index (RSI) 82.40 39.43
Support Level $22.00 $54.25
Resistance Level $36.67 $63.67
Average True Range (ATR) 0.04 2.08
MACD -0.37 -0.33
Stochastic Oscillator 90.00 8.06

Price Performance

Historical Comparison
PCRX
TFIN

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company based in the United States. Along with its subsidiaries, the company operates in four reportable segments: Banking, Factoring, Payments, and Intelligence. The Banking segment, which generates maximum revenue, includes the operations of TBK Bank, offering traditional banking services. The Factoring segment provides working capital solutions to the trucking industry through the purchase of invoices generated by carriers at a discount. The Payments segment provides payment, audit, and other banking services for the over-the-road trucking industry, and the Intelligence segment operates to turn the over-the-road trucking data collected through the services offered into actionable insights for its customers.

Share on Social Networks: